Does this mean persons with diabetes, with low income, will end up paying more for insulin, which they depend on to live, while persons , with low income, receiving l-dopa will pay less for their drug because if only prolongs their lives?

Sounds to me like the governments that regulate their pharmaceutical companies are trying to regulate ours as well. Maybe if our government would step up and do their job, it woudn't be necessary.

Vicky